Search Results

Site Search

Antibody Prevalence in Epilepsy and Encephalopathy (APE2 ) score - Insights

Antibody Prevalence in Epilepsy and Encephalopathy (APE2 ) score.

Mayo Clinic Laboratory and Pathology Research Roundup: May 21 - Insights

This week's research roundup feature: Monoclonal immunoglobulin (MIg) crystalline nephropathies are rare lesions resulting from precipitation of MIgs in the kidney as crystalline inclusions. They can be categorized into lesions with...

Sleep Disorder Testing - Mayo Clinic Laboratories

Determining orexin-A/ hypocretin-1 levels through CSF testing provides a sensitive and specific result to guide appropriate treatment for patients.

Urinary stone services - Insights

Learn how our approach to kidney stone services and concise reporting enable accurate interpretation to guide clinical decisions.

Independence Day Specimen Shipment Alert - Insights

Due to the Independence Day holiday, Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead.

Independence Day Specimen Shipment Alert - Insights

Due to the Independence Day holiday, Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead.

Memorial Day Specimen Shipment Alert - Insights

Due to the Memorial Day holiday (recognized on Monday, May 30), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please plan...

Memorial Day Specimen Shipment Alert - Insights

Due to the Memorial Day holiday (recognized on Monday, May 31), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead and...

Labor Day specimen shipment alert - Insights

Due to the Labor Day holiday (recognized on Monday, September 6), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered.

CPT codes and LOINC update: March 2024 - Insights

This page includes updates posted to Mayo Clinic Labs during the month of March.

Mayo Clinic Laboratory and pathology research roundup: July 4 - Insights

This week's research roundup feature: Emergence of inducible macrolide resistance in mycobacterium chelonae due to broad-host-range plasmid and chromosomal variants of the novel 23S rRNA methylase gene, erm(55).

Mayo Clinic Laboratory and pathology research roundup: September 12 - Insights

This week's research roundup feature: Activated mast cells in periprosthetic joint infection-associated tissue.

Mayo Clinic Laboratory and pathology research roundup: July 11 - Insights

This week's research roundup feature: Comparison of two assays to diagnose herpes simplex virus in patients with central nervous system infections.

Mayo Clinic, Thermo Fisher Scientific collaborate to benefit patients - Insights

Mayo Clinic and Thermo Fisher have joined forces to bring innovative solutions to patients.

Mayo Clinic Laboratory and Pathology Research Roundup: November 21 - Insights

This week's research roundup feature: Bicuspid aortic valve (BAV) is the most common congenital heart anomaly. Lifetime morbidity and whether long-term survival varies according to BAV patient-sub-groups are unknown. This study aimed to...

Mayo Clinic Laboratory and pathology research roundup: April 4 - Insights

This Feature Includes: Utility of Follow-up COVID-19 Antigen Tests After Acute SARS-CoV-2 Infection Among Healthcare Personnel.

Nuclear Magnetic Resonance Lipoprotein Profile [Test in Focus] - Insights

Jeffrey (Jeff) Meeusen, Ph.D., gives an overview of the new nuclear magnetic resonance (NMR) lipoprotein profile available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon...

High-Sensitivity Troponin T [Test in Focus] - Insights

High-sensitivity troponin T is a new assay recently approved by the U.S. Food and Drug Administration. This assay is most often used to evaluate patients with possible acute ischemic heart disease, but it also has a variety of uses in the...

New tests launched in September - Insights

In September 2021, Mayo Clinic Laboratories announced seven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

50th Anniversary Stories - Insights

From a small-scale enterprise with a two-man sales force and a limited testing menu, to a world-renowned reference lab with an expansive testing catalog featuring more than 3,500 assays, Mayo Clinic Laboratories has experienced significant...

Labor Day Holiday Shipment Schedules - Insights

Due to the Labor Day holiday (recognized on Monday, September 4th), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure specimen viability and avoid turnaround time delays, follow the guidelines...

Labor Day Specimen Shipment Alert - Insights

Due to the Labor Day holiday (recognized on Monday, September 5th), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead.

Bobbi Pritt, M.D., Featured on Mayo Clinic Radio to Discuss Lyme Disease Predictions for 2017 - Insights

On the April 22 broadcast of Mayo Clinic Radio, co-hosts Tracy McCray and Tom Shives, M.D., spoke with Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory, about an update on Lyme disease predictions for 2017.

General screening - Insights

Check out Mayo Clinic Laboratories’ expert-developed screening and panel testing for lysosomal disorders (LDs).

Week in Review: May 13 - Insights

Today's highlights include: Pandemic gets tougher to track as COVID testing plunges, Rochester hospitals score top grades in safety, and Mayo Clinic breaks ground on $155M Minnesota hospital expansion.

Week in Review: May 20 - Insights

Today's highlights include: US at risk of COVID-19 drug shortages this summer, Rochester startup Vyriad developing cancer-fighting viruses, and CDC expresses concern about possibility of undetected monkeypox spread in U.K.

COVID-19 weekly news: April 4-10 2022 - Insights

Topic's Include: Testing wastewater for COVID-19: The clearest path to understanding community infection, and the latest advice about COVID-19 boosters.

Reflex Test Guides Precise Care for Arsenic Exposure: Paul Jannetto, Ph.D. - Insights

Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' SPAS test identifies the form of arsenic present in patients with arsenic exposure. That information is important for determining the potential level of harm and for removing the...

Advancing our Understanding of Immunoglobulins to Better Understand Disease - Insights

PACE / State of FLIn this month’s “Virtual Lecture,” David Murray, M.D., Ph.D., discusses how immunoglobin light chains are used to detect overexpressed immunoglobins which can be applied to distinguish patients with plasma cell disorders...

Kelch-like protein 11 autoantibodies: A novel biomarker of testicular cancer associated neurological autoimmunity - Insights

The discovery of Kelch like protein 11 (KLHL11) IgG as a specific biomarker of neurological autoimmunity associated testicular germ cell tumor.

Phlebotomy Lab Operations - Insights

PACE / State of FL Phlebotomy and specimen collection services are on the forefront of patient diagnosis. However, more often than not, they are over shadowed by testing laboratories because they deliver the final test results. The focus of...

Blood Diversion/Culture Contamination - Insights

PACE/State of FL - Blood diversion as a mechanism to lower blood culture contamination rates.

Testing to Identify Clinically Significant Chromosomal Abnormalities - Insights

This week's featured chromosomal microarray test in focus is presented by William Sukov, M.D., a pathologist and cancer geneticist at Mayo Clinic. He discusses when this test should be used for patients with renal tumors.

Supporting Patient Care through Comprehensive Molecular and Cytogenetic Neuro-Oncology Testing - Insights

At Mayo Clinic, we offer a comprehensive approach to testing that focuses on the best outcomes for the patient. Our testing method combines molecular and cytogenetic analysis (in addition to a standard morphological and histological...

Understanding Membranoproliferative Glomerulonephritis, Including C3 Glomerulopathy: Part 2 - Insights

Membranoproliferative glomerulonephritis (MPGN) is a pattern of glomerular injury. Based on the etiology of MPGN, Drs. Sethi and Fervenza proposed a new histologic classification of MPGN into Ig/IC-mediated MPGN and complement-mediated...

Mayo Clinic Team to Combat Arboviruses and Future Infectious Disease Threats in Belize - Insights

Mayo Clinic and the University of Notre Dame’s Eck Institute for Global Health have launched a four-tiered joint project to better characterize and further assist in the detection of vector-borne infectious diseases in Belize.

Understanding Membranoproliferative Glomerulonephritis, Including C3 Glomerulopathy: Part 1 - Insights

Membranoproliferative glomerulonephritis (MPGN) is a pattern of glomerular injury. Based on the etiology of MPGN, Drs. Sethi and Fervenza proposed a new histologic classification of MPGN into Ig/IC-mediated MPGN and complement-mediated...

Giving thanks for years of prostate cancer treatment: Kurt Glover-Ettrich - Insights

After immigrating to the United State and becoming a U.S. citizen at the age of 18, Holocaust survivor Kurt Glover-Ettrich chose to give back to his new homeland by serving a 30-year career in the U.S. military. Today, as a Mayo Clinic...

Phlebotomy 2024 - Insights

This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...

Phlebotomy 2024 - Insights

This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...

Phlebotomy 2024 - Insights

This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...

Phlebotomy 2024 - Insights

This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...

Phlebotomy 2024 - Insights

This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...

Phlebotomy 2024 - Insights

This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...

Phlebotomy 2024 - Insights

This three-day virtual conference offered for just a few hours each day will offer the opportunity to learn techniques for managing burnout and ways to create a positive patient experience. Attendees will have the option to select from a...

Capabilities - Insights

Find out how our BioPharma Diagnostics capabilities can support your precision medicine initiatives, from discovery to post market.

Celiac disease - Insights

While the diagnostic criteria of celiac disease are well defined, symptoms are generally nonspecific. This fact, combined with the variety of available tests — each with a specific utility and interpretation — can make a diagnosis...

Fergus Couch, Ph.D., co-authors new guidelines for interpreting ATM cancer gene variants - Insights

Fergus Couch, Ph.D., chair of Mayo Clinic’s Division of Experimental Pathology and Laboratory Medicine, led a team that recently published new National Institutes of Health and U.S. Food and Drug Administration-approved guidelines for the...